Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
Vertex Pharmaceuticals (VX1) Ownership Overview
0.25% Insiders
35.42%
Mutual Funds
32.50% Other Institutional Investors
28.37% ETFs
3.45% Public Companies and
Individual Investors
The ownership structure of Vertex Pharmaceuticals (DE:VX1) stock is a mix of institutional, retail, and individual investors. Approximately 96.29% of the company’s stock is owned by Institutional Investors, 0.25% is owned by Insiders, and 3.45% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Aug 07, 2025 | xxxxxxxxxxxxx | $3895768 | |
Aug 07, 2025 | xxxxxxxxxxxxx | $1948416 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $57576 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $374928 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $483281 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $540858 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,477,640 | Institution | 8.06% | 10,103,237,546 | |
| 17,470,546 | Institution | 6.88% | 8,619,600,515 | |
| 16,598,256 | Institution | 6.53% | 8,189,230,947 | |
| 12,982,685 | Institution | 5.11% | 6,405,384,143 | |
| 9,814,883 | Institution | 3.86% | 4,842,457,160 | |
| 9,262,434 | Institution | 3.65% | 4,569,890,424 | |
| 5,437,002 | Institution | 2.14% | 2,682,502,610 | |
| 4,620,360 | Institution | 1.82% | 2,279,588,596 | |
| 4,450,840 | Institution | 1.75% | 2,195,950,988 | |
| 3,703,064 | Institution | 1.46% | 1,827,014,013 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,470,546 | Institution | 6.88% | 8,619,600,515 | |
| 12,982,685 | Institution | 5.11% | 6,405,384,143 | |
| 5,437,002 | Institution | 2.14% | 2,682,502,610 | |
| 4,620,360 | Institution | 1.82% | 2,279,588,596 | |
| 4,450,840 | Institution | 1.75% | 2,195,950,988 | |
| 3,703,064 | Institution | 1.46% | 1,827,014,013 | |
| 3,366,011 | Institution | 1.33% | 1,660,719,141 | |
| 2,971,156 | Institution | 1.17% | 1,465,905,976 | |
| 2,460,673 | Institution | 0.97% | 1,214,044,384 | |
| 2,392,362 | Institution | 0.94% | 1,180,341,171 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Vertex Pharmaceuticals (DE:VX1)?
According to the latest TipRanks data, approximately 32.50% of the company's stock is held by institutional investors, 0.25% is held by insiders, and 3.45% is held by retail investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 32.50% of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors?
According to the latest TipRanks data, approximately 3.45% of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors.
Who owns the most shares of Vertex Pharmaceuticals (DE:VX1)?
Vanguard owns the most shares of Vertex Pharmaceuticals (DE:VX1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.